About Scanadu

Scanadu is building a technology pulled right from the world of Star Trek. The Scanadu Tricorder integrates health diagnostics into your smartphone with the goal of creating a non-contact, non-invasive diagnostic tool for consumers. Scanadu has assembled top scientists, engineers, and biohackers at their lab in the NASA Ames Research Park, located in Silicon Valley, California. The first generation of the Tricorder is designed to help parents with young children turn anxiety into action.

Check your health as often as you check your email

Health care all over the world is broken. It is the last infrastructure of the industrial age that needs to be decentralized, deskilled and disintermediated so that a medical consumer takes the place of a patient (the end of patience). This new (DIY) market of autodiagnosis needs a new tool, the Tricorder, an expansion of one’s smart phone that can scan and track health in real time. This device will be non-contact and non-invasive in order to create an “indistinguishable from magic” experience for the consumer. We are partnering with NASA and other innovative technology institutions to bring this mythical device into reality. With millions of these Tricorders distributed all over the world, healthcare infrastructure will no longer be a failed economy and people will become the CEOs of their own health.

Google changed the paradigm of Information from an unfair game where some profit from things that others do not know (like poker) to a fair game where everyone knows all there is to know (like chess). The medical profession can benefit from the same disruptive transition.


Scanadu was incorporated in February 2011, but the mission to build the Tricorder has been on CEO Walter De Brouwer’s mind for 15 years. Back in the late 1990s, De Brouwer ran a deep science lab in Europe called Starlab and prototyped a Tricorder, but battery and storage limitations crippled functionality. In 2005, a family tragedy again got him thinking about the need to decentralize and deskill medicine. By 2010, the rise of smartphones and the Quantified Self made the Tricorder inevitable.

Scanadu secured its first investment at Singularity University’s FutureMed 2011, and moved to its NASA Ames lab in January 2012.

Competing for the X PRIZE

At CES on January 10th, Peter Diamandis, CEO of the X PRIZE Foundation, announced the Qualcomm Tricorder X PRIZE to spur the creation of a wireless, portable health device to monitor and diagnose one’s health conditions. To win the prize, Scanadu’s Tricorder must diagnose 15 distinct diseases in a group of 15 to 30 people. Most importantly, the tool must be used by a regular person, not a doctor or nurse.

Scanadu is the first company formed and funded explicitly to build the Tricorder, and is advised by a Medical Board including Dr. Daniel Kraft, Dr. Leslie Saxon, and Dr. Glenn Stettin. The Board of Directors includes Nicholas Negroponte and Stephen Wolfram.



Investors : investors@scanadu.com
Press : story@scanadu.com
Jobs : apply here
Scanadu HQ
NASA Ames Research Park, Building 20, 2nd Floor

Leave a Comment